Skip to content
10-Q

Quarterly Report

Milestone Pharmaceuticals Inc. MIST

0001104659-25-109689

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 12, 2025 85.17M sh
Capex Q3 2025 · Sep 30, 2025 $19K
Capex Q3 2025 · Sep 30, 2024 $11K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$36.27M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$22.01M
Long Term Debt Q3 2025 · Sep 30, 2025 $56.21M
Long Term Debt Q3 2025 · Dec 31, 2024 $53.35M
Short Term Investments Q3 2025 · Sep 30, 2025 $35.9M
Short Term Investments Q3 2025 · Dec 31, 2024 $44.38M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $46.69M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $25.31M
Stockholders Equity Q3 2025 · Sep 30, 2025 $20.5M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$17.75M
Stockholders Equity Q3 2025 · Dec 31, 2024 $13.15M
Stockholders Equity Q3 2025 · Sep 30, 2024 $24.01M
Stockholders Equity Q3 2025 · Jun 30, 2024 $31.98M
Stockholders Equity Q3 2025 · Dec 31, 2023 $16.77M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.52M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.13M
Total Liabilities Q3 2025 · Sep 30, 2025 $67.25M
Total Liabilities Q3 2025 · Dec 31, 2024 $62.35M
Current Assets Q3 2025 · Sep 30, 2025 $86.67M
Current Assets Q3 2025 · Dec 31, 2024 $73.93M
Total Assets Q3 2025 · Sep 30, 2025 $87.75M
Total Assets Q3 2025 · Dec 31, 2024 $75.5M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.60
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.14
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.12
Eps Basic Q3 2025 · Sep 30, 2025 −$0.60
Eps Basic Q3 2025 · Sep 30, 2024 −$0.14
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Sga Expense Q3 2025 · Sep 30, 2025 $3.26M
Sga Expense Q3 2025 · Sep 30, 2025 $12.19M
Sga Expense Q3 2025 · Sep 30, 2024 $3.74M
Sga Expense Q3 2025 · Sep 30, 2024 $12.74M
Rd Expense Q3 2025 · Sep 30, 2025 $3.94M
Rd Expense Q3 2025 · Sep 30, 2025 $12.59M
Rd Expense Q3 2025 · Sep 30, 2024 $3.96M
Rd Expense Q3 2025 · Sep 30, 2024 $10.42M
Net Income Q3 2025 · Sep 30, 2025 −$11.92M
Net Income Q3 2025 · Sep 30, 2025 −$45.65M
Net Income Q3 2025 · Sep 30, 2024 −$9.44M
Net Income Q3 2025 · Sep 30, 2024 −$29.16M
Operating Income Q3 2025 · Sep 30, 2025 −$11.83M
Operating Income Q3 2025 · Sep 30, 2025 −$44.88M
Operating Income Q3 2025 · Sep 30, 2024 −$9.62M
Operating Income Q3 2025 · Sep 30, 2024 −$29.75M
Stock Issued Q3 2025 · Jul 11, 2025 31.5M sh